Aging-like skin changes in metabolic syndrome model mice are mediated by mineralocorticoid receptor signaling

Aging Cell

Volumn 12, Issue 1, 2013, Pages 50-57

  Nagase, Takashi ^a   Akase, Tomoko ^a,d   Sanada, Hiromi ^a   Minematsu, Takeo ^a   Ibuki, Ai ^a   Huang, Lijuan ^a   Asada, Mayumi ^a   Yoshimura, Kotaro ^a   Nagase, Miki ^a   Shimada, Tsutomu ^b   Aburada, Masaki ^b   Nakagami, Gojiro ^c   Sugama, Junko ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b MUSASHINO UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Metabolic syndrome; Mineralocorticoid receptor; Oxidative stress; Skin aging; Spironolactone; Ultraviolet

Indexed keywords

MINERALOCORTICOID RECEPTOR; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SPIRONOLACTONE; TEMPOL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GENE EXPRESSION; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHOTOAGING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN DEFECT; ULTRAVIOLET IRRADIATION; UPREGULATION;

ANIMALS; DISEASE MODELS, ANIMAL; MALE; METABOLIC SYNDROME X; MICE; OXIDATIVE STRESS; RECEPTORS, MINERALOCORTICOID; SIGNAL TRANSDUCTION; SKIN; SKIN AGING; SKIN DISEASES;

MUS;

EID: 84872595536     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/acel.12017     Document Type: Article

References (44)

1. Afzali BM, Yaghoobi E, Yaghoobi R, Bagherani N, Dabbagh MA (2012) Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial. J Dermatolog Treat. 23, 21-25.
2. Akase T, Shimada T, Terabayashi S, Ikeya Y, Sanada H, Aburada M (2011) Antiobesity effects of Kaempferia parviflora in spontaneously obese type II diabetic mice. J. Nat. Med. 65, 73-80.
3. Akase T, Nagase T, Huang L, Ibuki A, Minematsu T, Nakagami G, Ohta Y, Shimada T, Aburada M, Sugama J, Sanada H (2012) Aging-like skin changes induced by ultraviolet irradiation in an animal model of metabolic syndrome. Biol Res Nurs. 14, 180-187.
4. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM (1987) Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237, 268-275.
5. Baxter JD, Funder JW, Apriletti JW, Webb P (2004) Towards selectively modulating mineralocorticoid receptor function: lessons from other systems. Mol. Cell. Endocrinol. 217, 151-165.
6. Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ (2006) Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126, 789-799.
7. Dröge W, Schipper HM (2007) Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell 6, 361-370.
8. Fadini GP, Ceolotto G, Pagnin E, de Kreutzenberg S, Avogaro A (2011) At the crossroads of longevity and metabolism: the metabolic syndrome and lifespan determinant pathways. Aging Cell 10, 10-17.
9. Farman N, Maubec E, Poeggeler B, Klatte JE, Jaisser F, Paus R (2010) The mineralocorticoid receptor as a novel player in skin biology: beyond the renal horizon? Exp. Dermatol. 19, 100-107.
10. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 908, 244-254.
11. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC, Salvioli S (2007) Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 128, 92-105.
12. Frisard M, Ravussin E (2006) Energy metabolism and oxidative stress: impact on the metabolic syndrome and the aging process. Endocrine 29, 27-32.
13. Fujita T (2010) Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome. Hypertension 55, 813-818.
14. Golden TR, Hinerfeld DA, Melov S (2002) Oxidative stress and aging: beyond correlation. Aging Cell 1, 117-123.
15. Goto M (2008) Inflammaging (inflammation + aging): a driving force for human aging based on an evolutionarily antagonistic pleiotropy theory? Biosci Trends. 2, 218-230.
16. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112, 2735-2752.
17. Guo C, Ricchiuti V, Lian BQ, Yao TM, Coutinho P, Romero JR, Li J, Williams GH, Adler GK (2008) Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines. Circulation 117, 2253-2261.
18. Hirata A, Maeda N, Hiuge A, Hibuse T, Fujita K, Okada T, Kihara S, Funahashi T, Shimomura I (2009) Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice. Cardiovasc. Res. 84, 164-172.
19. Hirayama I, Yi Z, Izumi S, Arai I, Suzuki W, Nagamachi Y, Kuwano H, Takeuchi T, Izumi T (1999) Genetic analysis of obese diabetes in the TSOD mouse. Diabetes 48, 1183-1191.
20. Hopps E, Noto D, Caimi G, Averna MR (2010) A novel component of the metabolic syndrome: the oxidative stress. Nutr Metab Cardiovasc Dis. 20, 72-77.
21. Inomata S, Matsunaga Y, Amano S, Takada K, Kobayashi K, Tsunenaga M, Nishiyama T, Kohno Y, Fukuda M (2003) Possible involvement of gelatinases in basement membrane damage and wrinkle formation in chronically ultraviolet B-exposed hairless mouse. J Invest Dermatol. 120, 128-134.
22. Kenouch S, Lombes M, Delahaye F, Eugene E, Bonvalet JP, Farman N (1994) Human skin as target for aldosterone: coexpression of mineralocorticoid receptors and 11 beta-hydroxysteroid dehydrogenase. J. Clin. Endocrinol. Metab. 79, 1334-1341.
23. Keyse SM, Tyrrell RM (1989) Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc. Natl Acad. Sci. USA 86, 99-103.
24. Maines MD (1997) The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37, 517-554.
25. Matsumoto Y, Ogawa Y, Yoshida R, Shimamori A, Kasai H, Ohta H (2008) The stability of the oxidative stress marker, urinary 8-hydroxy-2'- deoxyguanosine (8-OHdG), when stored at room temperature. J Occup Health. 50, 366-372.
26. McManus F, McInnes GT, Connell JM (2008) Drug Insight: eplerenone, a mineralocorticoid-receptor antagonist. Nat. Clin. Pract. Endocrinol. Metab. 4, 44-52.
27. Mitts TF, Bunda S, Wang Y, Hinek A (2010) Aldosterone and mineralocorticoid receptor antagonists modulate elastin and collagen deposition in human skin. J Invest Dermatol. 130, 2396-2406.
28. Mulatero P, Milan A, Williams TA, Veglio F (2006) Mineralocorticoid receptor blockade in the protection of target organ damage. Cardiovasc Hematol Agents Med Chem. 4, 75-91.
29. Nagase M (2010) Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome. Clin Exp Nephrol. 14, 303-314.
30. Nagase M, Fujita T (2008) Aldosterone and glomerular podocyte injury. Clin Exp Nephrol. 12, 233-242.
31. Nagase M, Yoshida S, Shibata S, Nagase T, Gotoda T, Ando K, Fujita T (2006) Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. J. Am. Soc. Nephrol. 17, 3438-3446.
32. Nagase M, Matsui H, Shibata S, Gotoda T, Fujita T (2007) Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress. Hypertension 50, 877-883.
33. National Research Council (1996) Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press.
34. Oberyszyn TM, Tober KL, Ross MS, Robertson FM (1998) Inhibitory effects of pentoxifylline on ultraviolet B light-induced cutaneous inflammation. Mol. Carcinog. 22, 16-25.
35. Odermatt A, Atanasov AG (2009) Mineralocorticoid receptors: emerging complexity and functional diversity. Steroids 74, 163-171.
36. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N. Engl. J. Med. 341, 709-717.
37. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 348, 1309-1321.
38. Rabe JH, Mamelak AJ, McElgunn PJ, Morison WL, Sauder DN (2006) Photoaging: mechanisms and repair. J. Am. Acad. Dermatol. 55, 1-19.
39. Roberts CK, Sindhu KK (2009) Oxidative stress and metabolic syndrome. Life Sci. 84, 705-712.
40. Sainte Marie Y, Toulon A, Paus R, Maubec E, Cherfa A, Grossin M, Descamps V, Clemessy M, Gasc JM, Peuchmaur M, Glick A, Farman N, Jaisser F (2007) Targeted skin overexpression of the mineralocorticoid receptor in mice causes epidermal atrophy, premature skin barrier formation, eye abnormalities, and alopecia. Am. J. Pathol. 171, 846-860.
41. Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, Miyoshi J, Takai Y, Fujita T (2008) Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat. Med. 14, 1370-1376.
42. Suzuki W, Iizuka S, Tabuchi M, Funo S, Yanagisawa T, Kimura M, Sato T, Endo T, Kawamura H (1999) A new mouse model of spontaneous diabetes derived from ddY strain. Exp. Anim. 48, 181-189.
43. Usher MG, Duan SZ, Ivaschenko CY, Frieler RA, Berger S, Schutz G, Lumeng CN, Mortensen RM (2010) Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J Clin Invest. 120, 3350-3364.
44. Zennaro MC, Caprio M, Feve B (2009) Mineralocorticoid receptors in the metabolic syndrome. Trends Endocrinol. Metab. 20, 444-451.